421192001: Sunitinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Angiogenesis inhibitor\Sunitinib (substance)
\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Sunitinib (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Sunitinib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Sunitinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Pyrrole\Sunitinib (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Pyrrole\Sunitinib (substance)
\Organic compound\Organic nitrogen compound\Azole\Pyrrole\Sunitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sunitinib (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Sunitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Sunitinib (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Sunitinib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Sunitinib (substance)	Is a	Azole	false	Inferred relationship	Some
Sunitinib (substance)	Is a	Pyrrole	true	Inferred relationship	Some
Sunitinib (substance)	Is a	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Sunitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Angiogenesis inhibitor (disposition)	true	Inferred relationship	Some
Sunitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Sunitinib (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Sunitinib (substance)	Is a	Angiogenesis inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing sunitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sunitinib (substance)	Inferred relationship	Some
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sunitinib (substance)	Inferred relationship	Some
Sunitinib (as sunitinib malate) 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sunitinib (substance)	Inferred relationship	Some
Sunitinib malate (substance)	Is a	False	Sunitinib (substance)	Inferred relationship	Some
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sunitinib (substance)	Inferred relationship	Some	1
Sunitinib (as sunitinib malate) 50 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sunitinib (substance)	Inferred relationship	Some	1
Sunitinib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sunitinib (substance)	Inferred relationship	Some	1
Sunitinib malate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sunitinib (substance)	Inferred relationship	Some
Sunitinib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sunitinib (substance)	Inferred relationship	Some	1
Sunitinib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 50 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 50 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 25 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 12.5 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Sunitinib (substance)	Inferred relationship	Some	1
Product containing precisely sunitinib 12.5 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Sunitinib (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2615165019	Sunitinib (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2617816010	Sunitinib	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
364781000195119	sunitinib	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
843251000172119	sunitinib	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3337031001000115	Sunitinib	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module